Concepedia

Publication | Open Access

Targeting Podoplanin for the Treatment of Osteosarcoma

28

Citations

27

References

2022

Year

Abstract

Targeting PDPN with a neutralizing antibody against PDPN-CLEC-2 without antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity is a novel therapeutic strategy for PDPN-positive osteosarcoma.

References

YearCitations

Page 1